References
- Rawla P, Sunkara T, Raj JP. Updated review of current pharmacological and non-pharmacological management of irritable bowel syndrome. Life Sci. 2018;212:176–181.
- Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017;6(11):99.
- Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology. 1991;100(4):998–1005.
- Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104(Suppl 1):S1–S35.
- Hasler WL. The irritable bowel syndrome during pregnancy. Gastroenterol Clin North Am. 2003;32(1):385–406, viii.
- Oh ST, Yedidag E, Bielefeldt K. Differential effects of progesterone and its analogues on the contractility of the murine jejunum in vitro. J Surg Res. 1998;75(1):1–5.
- Coşkun T, Sevinç A, Tevetoğlu I, et al. Delayed gastric emptying in conscious male rats following chronic estrogen and progesterone treatment. Res Exp Med. 1995;195(1):49–54.
- Dawson-Basoa M, Gintzler AR. Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems. Brain Res. 1998;794(1):61–67.
- Moosavi S, Pimentel M, Wong MS, et al. Irritable bowel syndrome in pregnancy. Am J Gastroenterol. 2021;116(3):480–490.
- Aksoy EK, Çetinkaya H, Savaş B, et al. Vascular endothelial growth factor, endostatin levels and clinical features among patients with ulcerative colitis and irritable bowel syndrome and among healthy controls: a cross-sectional analytical study. Sao Paulo Med J. 2018;136(6):543–550.
- Fan X, Rai A, Kambham N, et al. Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J Clin Invest. 2014;124(11):4941–4952.
- Sands BE, Duh MS, Cali C, et al. Algorithms to identify colonic ischemia, complications of constipation and irritable bowel syndrome in medical claims data: development and validation. Pharmacoepidemiol Drug Saf. 2006;15(1):47–56.
- Desai P, Mbachi C, Vohra I, et al. Association between cannabis use and healthcare utilization in patients with irritable bowel syndrome: a retrospective cohort study. Cureus. 2020;12(5):e8008.
- Sethi S, Wadhwa V, LeClair J, et al. In-patient discharge rates for the irritable bowel syndrome - an analysis of national trends in the United States from 1997 to 2010. Aliment Pharmacol Ther. 2013;38(11-12):1338–1346.
- Patel RS, Goyal H, Satodiya R, et al. Relationship of cannabis use disorder and irritable bowel syndrome (IBS): an analysis of 6.8 million hospitalizations in the United States. Subst Use Misuse. 2020;55(2):281–290.
- Khashan AS, Quigley EM, McNamee R, et al. Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2012;10(8):902–909.
- Saban R. Angiogenic factors, bladder neuroplasticity and interstitial cystitis-new pathobiological insights. Transl Androl Urol. 2015;4(5):555–562.
- Sundrani DP, Reddy US, Joshi AA, et al. Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia. Clin Epigenetics. 2013;5(1):6.
- Tomimatsu T, Mimura K, Matsuzaki S, et al. Preeclampsia: maternal systemic vascular disorder caused by generalized endothelial dysfunction due to placental antiangiogenic factors. Int J Mol Sci. 2019;20(17):4246.
- Bennett A, Chunilal S. Diagnosis and management of deep vein thrombosis and pulmonary embolism in pregnancy. Semin Thromb Hemost. 2016;42(7):760–773.
- Kourlaba G, Relakis J, Kontodimas S, et al. A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. Int J Gynaecol Obstet. 2016;132(1):4–10.
- Zöller B, Ohlsson H, Waehrens R, et al. Association of irritable bowel syndrome and venous thromboembolism. Scand J Gastroenterol. 2018;53(7):784–789.
- Martin-Viñas JJ, Quigley EM. Immune response in irritable bowel syndrome: a systematic review of systemic and mucosal inflammatory mediators. J Dig Dis. 2016;17(9):572–581.
- Spiller R, Major G. IBS and IBD – separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol. 2016;13(10):613–621.
- Ponomaryov T, Payne H, Fabritz L, et al. Mast cells granular contents are crucial for deep vein thrombosis in mice. Circ Res. 2017;121(8):941–950.
- Wang Y, Zheng G, Meng X, et al. The effects of VEGF on deep venous thrombosis in the perioperative period of elderly fracture patients. Pak J Pharm Sci. 2018;31(6(Special)):2799–2803.
- Gibson GT, Colley DP, McMichael AJ, et al. Congenital anomalies in relation to the use of doxylamine/dicyclomine and other antenatal factors: an ongoing prospective study. Med J Aust. 1981;1(8):410–414.
- Eltonsy S, Martin B, Ferreira E, et al. Systematic procedure for the classification of proven and potential teratogens for use in research. Birth Defects Res A Clin Mol Teratol. 2016;106(4):285–297.
- Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med. 1991;21(2):157–171.
- Longo SA, Moore RC, Canzoneri BJ, et al. Gastrointestinal conditions during pregnancy. Clin Colon Rectal Surg. 2010;23(2):80–89.
- Adibi N, Riahinejad S, Toghiani A, et al. Irritable bowel syndrome symptoms during pregnancy trimesters. J Res Med Sci. 2012;17(Spec 2):S171–S174.
- Lee C, Doo E, Choi JM, et al.; Brain-Gut Axis Research Group of Korean Society of Neurogastroenterology and Motility. The increased level of depression and anxiety in irritable bowel syndrome patients compared with healthy controls: systematic review and meta-analysis. J Neurogastroenterol Motil. 2017;23(3):349–362.
- Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(2):132–143.
- Corsetti M, Whorwell P. The global impact of IBS: time to think about IBS-specific models of care? Therap Adv Gastroenterol. 2017;10(9):727–736.
- Zhang QE, Wang F, Qin G, et al. Depressive symptoms in patients with irritable bowel syndrome: a meta-analysis of comparative studies. Int J Biol Sci. 2018;14(11):1504–1512.
- Kopczyńska M, Mokros Ł, Pietras T, et al. Quality of life and depression in patients with irritable bowel syndrome. Prz Gastroenterol. 2018;13(2):102–108.
- Fadgyas-Stanculete M, Buga AM, Popa-Wagner A, et al. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry. 2014;2(1):4.
- Manchia M, Carpiniello B, Valtorta F, et al. Serotonin dysfunction, aggressive behavior, and mental illness: exploring the link using a dimensional approach. ACS Chem Neurosci. 2017;8(5):961–972.
- Whorwell PJ, Lupton EW, Erduran D, et al. Bladder smooth muscle dysfunction in patients with irritable bowel syndrome. Gut. 1986;27(9):1014–1017.
- Martínez-Martínez LA, Mora T, Vargas A, et al. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J Clin Rheumatol. 2014;20(3):146–150.